Northland Lateral Hip Pain Platelet-Rich Plasma Treatment Study

Northland, New Zealand Musculoskeletal Group Study on the effectiveness of Platelet-Rich Plasma for the treatment of Greater Trochanteric Pain Syndrome.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612000982819

Enrollment

Registered

2012-09-12

Start date

2013-02-15

Completion date

2013-04-12

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Double blinded randomised comparison of single injection of Platelet-Rich Plasma for the treatment of Greater Trochanteric Pain Syndrome.

Interventions

60 millilitres of blood will be drawn from the participant, and this will be immediately centrifuged to produce 5-6 millilitres of platelet-rich plasma which will be then given with local anaesthetic as a single once-off injection into the focal area of pain and tenderness over the outer hip. The process from taking the blood to doing the injection should be under 20 minutes.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

Spontaneous pain in the lateral aspect of the hip

Exclusion criteria

Serious medical or psychologic disorders, History of operation in the same area, Anti-coagulants, Pregnancy, High performance athletes, Low haemoglobin or platelet count, inability to understand questionnaires.

Outcome results